NEXTBIOMEDICAL Co., Ltd.
Develops polymer-based drug-device solutions for hemostasis and drug delivery worldwide.
389650 | KO
Overview
Corporate Details
- ISIN(s):
- KR7389650003
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 벤처로100번길 6, 인천광역시
- Website:
- https://nextbiomedical.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NEXTBIOMEDICAL Co., Ltd. is a global company specializing in innovative therapeutic solutions designed to address unmet clinical needs. The company develops and commercializes first-in-class products based on its proprietary polymer core technology, which enables advanced drug-device combination platforms. Key technologies include biodegradable adhesive polymers and resorbable microspheres for applications like sustained drug delivery. A flagship product is Nexpowder, an endoscopic hemostatic agent for gastrointestinal bleeding. Through strategic global partnerships, including a collaboration with Medtronic, NEXTBIOMEDICAL aims to establish its innovations as new standards of care worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-09-05 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 947.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 792.4 KB | ||
| 2025-03-31 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 98.2 KB | ||
| 2025-03-24 00:00 |
AGM Information
정기주주총회결과
|
Korean | 20.3 KB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 22.7 KB | ||
| 2025-03-13 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.1 MB | ||
| 2025-03-11 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 88.0 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 84.7 KB | ||
| 2025-02-20 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 23.4 KB | ||
| 2025-02-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.2 KB | ||
| 2025-02-12 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 14.9 KB | ||
| 2025-02-04 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2024-12-24 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB |
Automate Your Workflow. Get a real-time feed of all NEXTBIOMEDICAL Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEXTBIOMEDICAL Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEXTBIOMEDICAL Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}